Allergan Receives Third “Approvable” Letter For Combigan In Intraocular Pressure
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is counting on a confirmatory trial initiated in 2005 to satisfy FDA concerns regarding the glaucoma treatment.